Response-oriented individualized induction therapy followed by intensive consolidation and maintenance for adult patients with acute lymphoblastic leukemia: The ALL-87 study of the Japan Adult Leukemia Study Group (JALSG)

International Journal of Hematology

Volumn 68, Issue 4, 1998, Pages 421-429

  Tanimoto, Mitsune ^a   Miyawaki, Shuichi ^b   Ino, Teruo ^c   Kyo, Taiichi ^d   Hisashi Sakamaki, ^e   Naoe, Tomiki ^f   Hiraoka, Akira ^g   Asou, Norio ^h   Ohshima, Toshiteru ⁱ   Tsubaki, Kazuo ^j   Kuriyama, Kazutaka ^k   Ueda, Takanori ^l   Minamil, Sabro ^m   Okabe, Ken Ichi ⁿ   Saito, Hidehiko ^a   Murakami, Hirokazu ^b   Hirano, Masami ^c   Dohy, Hiroo ^d   Onozawa, Yasusuke ^e   Suzuki, Hisamitsu ^o   Ohno, Ryuzo ^p   more..

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b GUNMA UNIVERSITY HOSPITAL   (Japan)

^c FUJITA HEALTH UNIVERSITY HOSPITAL   (Japan)

^d Hiroshima Red Cross Atomic Bomb Hospital   (Japan)

^e TOKYO METROPOLITAN KOMAGOME HOSPITAL   (Japan)

^f NAGOYA UNIVERSITY HOSPITAL   (Japan)

^g CENTER FOR ADULT DISEASES   (Japan)

^h KUMAMOTO UNIVERSITY HOSPITAL   (Japan)

ⁱ SURUGADAI NIHON UNIVERSITY HOSPITAL   (Japan)

^j KINDAI UNIVERSITY HOSPITAL   (Japan)

^k NAGASAKI UNIVERSITY HOSPITAL   (Japan)

^l UNIVERSITY OF FUKUI HOSPITAL   (Japan)

^m JAPANESE RED CROSS NAGOYA FIRST HOSPITAL   (Japan)

ⁿ NATIONAL HOSPITAL ORGANIZATION SHIKOKU CANCER CENTER   (Japan)

^o AICHI CANCER CENTER HOSPITAL   (Japan)

^p HAMAMATSU UNIVERSITY HOSPITAL   (Japan)

more..

Author keywords

Acute lymphoblastic leukemia; Adult; Chemotherapy; Individualized therapy; Response oriented therapy

Indexed keywords

ACLARUBICIN; ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; MERCAPTOPURINE; METHOTREXATE; MITOXANTRONE; PREDNISOLONE; VINCRISTINE; VINDESINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGE; AGED; ALOPECIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER REGRESSION; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG RESPONSE; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMAN; INFECTION; INTRAMUSCULAR DRUG ADMINISTRATION; INTRATHECAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; PANCREATITIS; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE COUNT; VOMITING;

EID: 0031793678     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0925-5710(98)00084-x     Document Type: Article

References (23)

1. Rivera G.K., Pinkel D., Simone J.V., Hancock M.L., Crist W.M. Treatment of acute lymphoblastic leukemia - 30 years' experience at St. Jude Children's Research Hospital. New Engl J Med. 329:1993;1289-1895.
2. Schauer P., Arlin Z.A., Mertelsmann R., Cirrincione C., Friedman A., Gee T.S.et al. Treatment of acute lymphoblastic leukemia in adults: Results of the L-10 and L10M protocols. J Clin Oncol. 8:1983;462-470.
3. Linker C.A., Levitt L.J., O'Donnell M., Reis C.A., Link M.P., Forman S.J.et al. Improved results of treatment of adult acute lymphoblastic leukemia. Blood. 69:1987;1242-1248.
4. Hoelzer D., Thiel E., Lugwig W.D., Buchner T., Freund M., Heil G.et al. The German multicentre trials for treatment of acute lymphoblastic leukemia in adults. Leukemia. 6:1992;175-177.
5. Hoelzer D. Acute lymphoblastic leukemia - progress in children, less in adults. New Engl J Med. 329:1993;1343-1344.
6. Hoelzer D. Aggressive chemotherapy of ALL in elderly patients. Hematol Oncol. 11:1993;12.
7. Ohno R., Kobayashi T., Tanimoto M., Hiraoka A., Imai K., Asou N.et al. Randomized study of individualized induction therapy with or without vincristine, and of maintenance-intensification therapy between 4 or 12 courses in adult acute myeloid leukemia: AML Study of the Japan Adult Leukemia Study Group. Cancer. 71:1993;3888-3895.
8. Kobayashi T., Miyawaki S., Tanimoto M.et al. Randomized trials between behenoyl cytarabine and cytarabine in combination induction and consolidation therapy, and with or without ubenimex after maintenance/intensification therapy in adult acute myeloid leukemia. J Clin Oncol. 14:1996;204-213.
9. Bennet J.M., Catovsky D., Daniel M.T., Flandrin G., Galton D.A.G., Gralnick H.R.et al. Proposed revised criteria for the classification of acute myeloid leukemia. Ann Intern Med. 103:1985;626-629.
10. Cuttner J., Mick R., Budman D.R., Mayer R.J., Lee E.J., Henderson E.S.et al. Phase III trial of brief intensive treatment of acute lymphocytic leukemia comparing Daunorubicin and Mitoxantrone: A CALGB study. Leukemia. 5:1991;425-431.
11. Stryckmans P., de Witte T., Marie J.P., Fillet G., Peetermans M., Bury J.et al. Therapy of adult ALL: overview of two successive EORTC studies: (ALL-2 and ALL-3). Leukemia. 6:1992;199-203.
12. GIMEMA Cooperative Group: GIMEMA ALL 0183 A multicentric study on acute lymphoblastic leukemia in Italy. Br J Haematol. 71:1989;377-386.
13. Hoelzer D., Thiel E., Loffler H., Buchner T., Ganser A., Heil G.et al. Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults. Blood. 71:1988;123-131.
14. Hussein K.K., Dahlberg S., Head D., Waddell C., Dabich L., Weick J.K.et al. Treatment of acute lymphoblastic leukemia in adults with intensive induction consolidation, and maintenance chemotherapy. Blood. 73:1989;57-63.
15. Oh H, Gale RP, Zhang MJ, Passweg JR, Ino T, Murakami H, et al. Chemotherapy versus HLA-identical sibling transplants for adults with acute lymphoblastic leukemia in first remission. Bone Marrow Transplant 1998;22:253-7.
16. Westbrook C.A., Hooberman A.L., Spino C., Dodge R.K., Larson R.A., Davey F.et al. Clinical significance of the BCR-ABL fusion gene in adult acute lymphoblastic leukemia: a Cancer and Leukemia Group B study (8762). Blood. 80:1992;2983-2990.
17. Radich J.P., Kopecky K.J., Boldt D.H., Head D., Slovak M.L., Babu R.et al. Detection of BCR-ABL fusion genes in adult acute lymphoblastic leukemia by the polymerase chain reaction. Leukemia. 8:1994;1688-1695.
18. Secker-Walker L.M., Craig J.M., Hawkins J.M., Hoffbrand A.V. Philadelphia positive acute lymphoblastic leukemia in adults: age distribution. BCR breakpoint and prognostic significance. Leukemia. 5:1991;196-199.
19. Maurer J., Janssen J.W.G., Thiel E., van Denderen J., Ludwig W.D., Aydemir U. Detection of chimeric BCR-ABL genes in acute lymphoblastic leukaemia by the polymerase chain reaction. Lancet. 337:1991;1055-1058.
20. Ellison R.R., Mick R., Cuttner J., Schiffer C.A., Silver R.T., Henderson E.S.et al. The effects of postinduction intensification treatment with cytarabine and daunorubicin in adult acute lymphocytic leukemia: a prospective randomized clinical trial by Cancer and Leukemia Group B. J Clin Oncol. 9:1991;2002-2015.
21. Schwenn M.R., Blattner S.R., Lynch E., Weinstein H.J. HiC-COM: A 2-month intensive chemotherapy regimen for children with stage III and IV Burkitt's lymphoma and B-cell acute lymphoblastic leukemia. J Clin Oncol. 9:1991;133-138.
22. Reiter A., Schrappe M., Ludwig W.-D., Lampert F., Harbott J., Hemze G.et al. Favorable outcome of B-cell acute lymphoblastic leukemia in childhood: a report of three consecutive studies of the BFM group. Blood. 80:1992;2471-2478.
23. Gale R.P., Butturini A., Horowitz M.M. Does more intensive therapy increase cure in acute leukemia? Semin Hematol. 28(Suppl 4):1991;93-94.